Sonia Reyes
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Tocotrienol-rich vitamin E complex in CADASIL (T3CAD): a randomised, double-blind, placebo-controlled trial.
Journal: EClinicalMedicine
Published: February 21, 2026
Determining Clinical Disease Progression in Symptomatic Patients With CADASIL.
Journal: Neurology
Published: December 17, 2024
Prevalence and characteristics of vascular cognitive impairment in a European cohort of adult patients with Moyamoya angiopathy.
Journal: Journal of neurology
Published: March 21, 2024
Inaugural late-onset temporal lobe epilepsy as a new non-cognitive Alzheimer's disease phenotype.
Journal: Revue neurologique
Published: February 15, 2023
Psychological impact of COVID-19 containment on CADASIL patients.
Journal: Journal of neurology
Published: January 16, 2023
SAFETY AND EFFICACY OF THYMIC PEPTIDES IN THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS IN HONDURAS.
Journal: Georgian medical news
Published: November 25, 2022
Trajectory Pattern of Cognitive Decline in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.
Journal: Neurology
Published: January 03, 2022
Modeling the Cognitive Trajectory in CADASIL.
Journal: Journal of Alzheimer's disease : JAD
Published: August 18, 2020
French clinical practice guidelines for Moyamoya angiopathy.
Journal: Revue neurologique
Published: October 09, 2017
Reaction Time Is Negatively Associated with Corpus Callosum Area in the Early Stages of CADASIL.
Journal: AJNR. American journal of neuroradiology
Published: March 01, 2017
Reaction Time is a Marker of Early Cognitive and Behavioral Alterations in Pure Cerebral Small Vessel Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: September 25, 2015
Last Updated: 09/26/2026